Article PDF
References
Gruters, R. A. et al. Nature 330, 74–77 (1987).
Walker, B. D. et al. Proc. natn. Acad. Sci U.S.A. 84, 8120–8124 (1987).
Karpas, A. et al. Proc. natn. Acad. Sci. U.S.A. 85, 9229–9233 (1988).
Fleet, G. W. J. et al. FEBS Lett. 237, 128–132 (1988).
Pal, R. et al. Intervirology 30, 27–35 (1989).
Ratner, L. et al. Virology 181, 180–192 (1991).
Morikawa, Y. et al. AIDS Res. Hum. Retrovir. 6, 765 (1990).
Hattori, T. et al. FEBS Lett. 248, 48–52 (1989).
Clements, G. J. et al. AIDS Res. Hum. Retrovir. 7, 3 (1991).
Morikawa, Y. et al. J. virol. Meth. 29, 105–114 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
JONES, I., JACOB, G. Anti-HIV drug mechanism. Nature 352, 198 (1991). https://doi.org/10.1038/352198b0
Issue Date:
DOI: https://doi.org/10.1038/352198b0
This article is cited by
-
The hyperglycosylation of HIV envelope: An opportunity to alter virus infectivity?
Perspectives in Drug Discovery and Design (1996)
-
Iminosugar glycosylation inhibitors as anti-HIV agents
Perspectives in Drug Discovery and Design (1993)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.